Cefoperazone Sulbactam Injection is a combination antibacterial medicine used in the treatment of certain bacterial infections caused by susceptible organisms. It contains two active ingredients: cefoperazone, a third-generation cephalosporin antibiotic, and sulbactam, a beta-lactamase inhibitor.
The combination is used in hospital and clinical settings where a healthcare professional determines that injectable antibiotic treatment is appropriate. Its use depends on the type of infection, likely or confirmed bacteria, susceptibility results and the patient’s medical condition.
At Scotmed Care, we provide pharmaceutical product information and B2B supply support for critical care injections, including Cefoperazone & Sulbactam for Injection 1.5 g, marketed under the brand CEFOCOT-S 1.5.
This guide explains cefoperazone sulbactam injection uses, its composition, mechanism of action, key clinical benefits, safety precautions and pharmaceutical sourcing options.
What Is Cefoperazone Sulbactam Injection?
Cefoperazone Sulbactam Injection is a prescription antibacterial preparation combining a cephalosporin antibiotic with a beta-lactamase inhibitor.
Cefoperazone acts against susceptible bacteria by disrupting bacterial cell wall synthesis.
Sulbactam helps protect cefoperazone against certain beta-lactamase enzymes produced by bacteria. These enzymes can otherwise reduce the effectiveness of some beta-lactam antibiotics.
The combination may offer antibacterial activity against susceptible organisms in clinical circumstances where both components are appropriate.
However, not every bacterial strain is sensitive to this medicine. The combination should not be described as effective against all infections or every antibiotic-resistant organism.
A registered medical practitioner must determine whether cefoperazone and sulbactam are appropriate for a particular infection.
How Does Cefoperazone Sulbactam Injection Work?
The two active ingredients have complementary functions.
Cefoperazone – Antibacterial Activity
Cefoperazone is a third-generation cephalosporin antibiotic. It inhibits bacterial cell wall synthesis by interacting with proteins involved in cell wall formation.
This process can result in the death of susceptible bacteria.
Sulbactam – Beta-Lactamase Inhibition
Sulbactam inhibits certain bacterial beta-lactamase enzymes.
By inhibiting susceptible enzymes, it may help preserve the antibacterial action of cefoperazone.
Sulbactam does not overcome every resistance mechanism, so microbiological susceptibility and clinical guidance remain important.
Together, these ingredients provide a combination treatment option for selected bacterial infections.
Cefoperazone Sulbactam Injection Uses
Cefoperazone Sulbactam Injection uses include the treatment of certain infections caused by susceptible bacteria.
The exact approved indications vary according to the registered product, country and prescribing information.
1. Respiratory Tract Infections
Cefoperazone and sulbactam may be used for selected bacterial respiratory tract infections, including certain cases of pneumonia, when the causative bacteria are susceptible and treatment is clinically indicated.
The medicine does not treat viral infections such as the common cold or influenza.
2. Urinary Tract Infections
Some registered cefoperazone-sulbactam formulations are indicated for urinary tract infections caused by susceptible organisms.
Treatment decisions depend on the site and severity of infection, patient characteristics and available microbiological results.
3. Intra-Abdominal Infections
The combination may be used in selected intra-abdominal bacterial infections, including certain cases of peritonitis, cholecystitis and other infections involving abdominal structures.
Some of these conditions require surgery, drainage or other forms of source control in addition to antibiotics.
4. Skin, Soft Tissue, Bone and Joint Infections
Cefoperazone and sulbactam may be considered for certain bacterial infections affecting the skin, soft tissues, bones or joints, provided that the responsible organisms are susceptible and the specific product is approved for the indication.
Treatment is determined by the diagnosis, infection severity and appropriate clinical guidelines.
5. Bloodstream and Other Serious Bacterial Infections
Certain registered combination formulations include septicemia and other serious infections among their approved indications.
Serious bloodstream infections and sepsis require urgent assessment, appropriate antimicrobial therapy and supportive medical care.
Antibiotic selection should follow local clinical protocols and, where possible, microbiological findings.
Important: Cefoperazone Sulbactam Injection should be used only when prescribed by a qualified healthcare professional. Inappropriate antibiotic use contributes to antimicrobial resistance.
Five Key Clinical Benefits of Cefoperazone Sulbactam Injection
1. Combination Antibacterial Mechanism
Cefoperazone provides the principal antibacterial effect, while sulbactam inhibits certain beta-lactamase enzymes.
This combination can be useful when the infection involves susceptible organisms.
2. Activity Against Selected Gram-Positive and Gram-Negative Bacteria
Cefoperazone-sulbactam formulations have antibacterial activity against a range of susceptible organisms.
Actual susceptibility varies between bacterial species, strains and local resistance patterns.
3. Treatment Option for Serious Infections
The injectable formulation provides clinicians with a treatment option for selected infections requiring hospital-based antibacterial therapy.
4. Intravenous and Intramuscular Presentations
Some approved formulations, including Scotmed Care’s CEFOCOT-S 1.5 listing, are intended for intramuscular or intravenous administration.
The route of administration must follow the specific product’s approved prescribing instructions.
5. Support for Susceptibility-Guided Antibiotic Treatment
The combination can form part of an antibiotic regimen selected according to clinical diagnosis, microbiological results and professional prescribing guidelines.
These benefits do not guarantee faster recovery or successful treatment in every patient.
Cefoperazone Sulbactam Injection 1.5 g – CEFOCOT-S
Scotmed Care lists Cefoperazone & Sulbactam for Injection 1.5 g (CEFOCOT-S 1.5) within its critical care pharmaceutical product range.
Buyers can view the official Cefoperazone & Sulbactam for Injection 1.5 g (CEFOCOT-S 1.5) product page for the current product listing and commercial enquiries.
Product Information
| Product Specification | Details |
|---|---|
| Generic Name | Cefoperazone + Sulbactam |
| Brand Name | CEFOCOT-S 1.5 |
| Total Labeled Strength | 1.5 g |
| Dosage Form | Injection |
| Therapeutic Category | Cephalosporin Combination Antibacterial |
| Administration | I.M. / I.V., as approved |
| Business Supply | Hospital, wholesale and institutional enquiries |
| Company | Scotmed Care |
The exact cefoperazone-to-sulbactam component ratio and pharmaceutical excipients must be checked against the current CEFOCOT-S 1.5 pack insert before publishing a detailed composition statement.
The product is intended for professional medical use.
Cefoperazone Sulbactam Injection Side Effects
Like other antibiotics, cefoperazone and sulbactam may cause adverse reactions.
Reported effects can include:
- Diarrhoea or loose stools
- Nausea and gastrointestinal discomfort
- Injection-site pain
- Hypersensitivity reactions
- Temporary changes in liver enzyme levels
- Blood count abnormalities
- Coagulation-related abnormalities
Serious allergic reactions and antibiotic-associated colitis are important potential risks.
Patients experiencing severe diarrhoea, breathing difficulty, swelling, unusual bleeding or other concerning symptoms require prompt medical assessment.
The full adverse-reaction profile should be checked against the approved product information.
Precautions and Contraindications
Before administering Cefoperazone Sulbactam Injection, healthcare professionals should review the patient’s medical history and relevant clinical risks.
Allergy to Beta-Lactam Antibiotics
The medicine may be contraindicated in patients with known serious hypersensitivity to the formulation or relevant beta-lactam antibiotics.
A history of allergy to penicillins or cephalosporins requires careful evaluation.
Liver and Kidney Function
Cefoperazone is substantially eliminated through the biliary system, while sulbactam is primarily eliminated through the kidneys.
Relevant organ dysfunction may affect treatment decisions and monitoring.
Bleeding and Coagulation
Cefoperazone-containing preparations may be associated with hypoprothrombinemia and bleeding-related complications in susceptible patients.
Clinicians should consider relevant nutritional, medical and medication-related risk factors.
Antibiotic-Associated Diarrhoea
Persistent or severe diarrhoea during or after antibiotic treatment may indicate antibiotic-associated colitis, including Clostridioides difficile infection.
Medical evaluation is important.
Alcohol Consumption
Some cefoperazone-containing formulations may cause a disulfiram-like reaction when alcohol is consumed during treatment or shortly afterward.
Patients should follow the precautions specified in the approved prescribing information.
Pregnancy and Breastfeeding
Use during pregnancy or breastfeeding requires assessment of the potential benefits and risks by a qualified clinician.
Dosage, Administration and Storage
Cefoperazone Sulbactam Injection must be prepared and administered by trained healthcare professionals.
Dosage and administration depend on several factors, including:
- Type and severity of infection
- Patient age and clinical condition
- Suspected or confirmed bacterial pathogen
- Renal and hepatic function
- Relevant prescribing guidelines
- Approved product formulation
The medicine may be administered by intramuscular or intravenous routes where authorized.
Reconstitution, dilution, compatibility, infusion procedures and storage requirements must follow the manufacturer-approved instructions.
The product should not be self-administered.
Because formulations and stability conditions differ, a general room-temperature storage instruction should not replace the specific product label.
Cefoperazone Sulbactam Injection Supplier in India – Scotmed Care
Scotmed Care’s pharmaceutical injection portfolio includes products for hospital, institutional and pharmaceutical distribution enquiries.
Scotmed Care supports eligible B2B customers looking for Cefoperazone Sulbactam Injection supply in India, including requests relating to CEFOCOT-S 1.5.
Our business enquiry services are relevant to pharmaceutical wholesalers, distributors, hospital procurement departments and institutional medical suppliers.
Buyers can also explore the broader Scotmed Care product list to review additional formulations.
When placing an enquiry, pharmaceutical buyers should specify the required composition, strength, packaging, quantity and delivery location.
Current stock, batch availability, order requirements and commercial terms must be confirmed before purchase.
Third-Party Manufacturing – Scotmed Care and Medizia Biotech
Scotmed Care supports pharmaceutical sourcing and manufacturing-related business enquiries through its supply network and its association with Medizia Biotech.
Customers interested in third-party pharmaceutical manufacturing may enquire about:
- Injectable pharmaceutical formulations
- Product specifications and composition
- Suitable manufacturing arrangements
- Packaging and labeling requirements
- Commercial order quantities
- Available regulatory and quality documentation
- Supply and delivery arrangements
You can learn more about the company’s pharmaceutical activities through the Scotmed Care About Us page.
Where manufacturing is arranged through a WHO-GMP-certified facility, the relevant site certification should be verified.
Actual third-party manufacturing availability depends on licensed production capabilities, formulation feasibility, product approvals and applicable commercial conditions.
Frequently Asked Questions About Cefoperazone Sulbactam Injection
What is Cefoperazone Sulbactam Injection used for?
It is used for certain bacterial infections caused by susceptible organisms. Depending on the approved formulation, uses may include selected respiratory, urinary, intra-abdominal, skin and soft tissue, and serious systemic infections.
How does Cefoperazone Sulbactam Injection work?
Cefoperazone inhibits bacterial cell wall synthesis. Sulbactam inhibits certain beta-lactamase enzymes that can otherwise reduce the activity of some beta-lactam antibiotics.
Is Cefoperazone Sulbactam Injection used for pneumonia?
Some registered formulations may be used for bacterial pneumonia caused by susceptible organisms. A doctor must determine whether it is appropriate.
What is Cefoperazone Sulbactam Injection 1.5 g?
It refers to a formulation containing a total labeled quantity of 1.5 g of the combined active ingredients. The exact ratio should be confirmed from the product label.
Is Cefoperazone Sulbactam Injection effective against viral infections?
No. It is an antibacterial medicine and does not treat infections caused by viruses.
What are the common side effects?
Potential adverse effects include gastrointestinal discomfort, diarrhoea, injection-site reactions, allergic reactions and changes in laboratory parameters.
Is CEFOCOT-S 1.5 available through Scotmed Care?
Scotmed Care lists CEFOCOT-S 1.5 as a pharmaceutical injection product. Buyers should contact the company to confirm current availability and commercial terms.
Does Scotmed Care support bulk pharmaceutical supply?
Yes. Scotmed Care accepts B2B enquiries from eligible pharmaceutical distributors, wholesalers, hospitals and institutional buyers.
Conclusion
Cefoperazone Sulbactam Injection is a prescription antibacterial combination used for selected bacterial infections caused by susceptible organisms.
The two active ingredients work through complementary mechanisms: cefoperazone interferes with bacterial cell wall synthesis, while sulbactam inhibits certain beta-lactamase enzymes.
Appropriate antibiotic selection, professional administration and monitoring are essential for effective and responsible treatment.
For pharmaceutical businesses seeking Cefoperazone Sulbactam Injection 1.5 g, CEFOCOT-S 1.5 product information, wholesale supply or third-party manufacturing support, Scotmed Care provides dedicated B2B enquiry assistance.
Contact Scotmed Care for Pharmaceutical Business Enquiries
Company: Scotmed Care Pvt. Ltd.
Website: https://www.scotmedcare.com/
Email: info@scotmedcare.com
Phone: +91 86840 53030 / +91 87086 44865
Contact Scotmed Care for product specifications, current availability and bulk supply quotations.
Medical References
- Karnataka Antibiotics & Pharmaceuticals Limited – Cefoperazone Sulbactam Product Information
- Bosch Pharmaceuticals – Cefoperazone Sulbactam Prescribing Information
Medical Disclaimer: This article is for pharmaceutical trade information and general educational reference only. It is not intended as individual medical advice. Approved indications, composition, dosage, contraindications, administration and storage must be verified from the specific registered product’s prescribing information. Antibiotics should only be used as directed by a qualified healthcare professional.